{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:12:26Z","timestamp":1780362746423,"version":"3.54.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231027","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T13:37:42Z","timestamp":1585834662000},"page":"e0231027","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-8753","authenticated-orcid":true,"given":"Thomas W.","family":"Georgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-1610","authenticated-orcid":true,"given":"Dirk","family":"Hasenclever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria S.","family":"Warbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4381-3349","authenticated-orcid":true,"given":"Lucy","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally F.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"pone.0231027.ref001","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1182\/asheducation.V2012.1.322.3800161","article-title":"How does PET\/CT help in selecting therapy for patients with Hodgkin lymphoma?","volume":"2012","author":"M Hutchings","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"pone.0231027.ref002","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1200\/JCO.2011.41.1819","article-title":"Long-Term Results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin\u2019s lymphoma\u2014a report from the Children\u2019s Oncology Group","volume":"30","author":"SL Wolden","year":"2012","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref003","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma","volume":"373","author":"M Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0231027.ref004","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","article-title":"Pediatric Hodgkin Lymphoma","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"pone.0231027.ref005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas","volume":"44","author":"SF Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref006","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma","volume":"374","author":"P Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0231027.ref007","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2015.63.0699","article-title":"Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study","volume":"34","author":"PL Zinzani","year":"2016","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref008","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I\/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC\/LYSA\/FIL H10 Trial","volume":"32","author":"JM Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref009","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"J Radford","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0231027.ref010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(11)61940-5","article-title":"Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial","volume":"379","author":"A Engert","year":"2012","journal-title":"Lancet"},{"key":"pone.0231027.ref011","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00247-012-2559-z","article-title":"FDG PET\/CT in children and adolescents with lymphoma","volume":"43","author":"R Kluge","year":"2013","journal-title":"Pediatr Radiol"},{"key":"pone.0231027.ref012","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"SF Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bjh.12601","article-title":"When should FDG-PET be used in the modern management of lymphoma?","volume":"164","author":"SF Barrington","year":"2014","journal-title":"Br J Haematol"},{"key":"pone.0231027.ref014","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study","volume":"25","author":"A Gallamini","year":"2007","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the First International Workshop on interim-PET scan in lymphoma","volume":"50","author":"M Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"pone.0231027.ref016","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1080\/10428194.2017.1298752","article-title":"Report of the 6th International Workshop on PET in lymphoma","volume":"58","author":"C Nanni","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"pone.0231027.ref017","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"BD Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref018","doi-asserted-by":"crossref","first-page":"e0149072","DOI":"10.1371\/journal.pone.0149072","article-title":"Inter-Reader Reliability of Early FDG-PET\/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma","volume":"11","author":"R Kluge","year":"2016","journal-title":"PLoS One"},{"key":"pone.0231027.ref019","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2009-08-234351","article-title":"Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study","volume":"115","author":"SJ Horning","year":"2010","journal-title":"Blood"},{"key":"pone.0231027.ref020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2009-09-244947","article-title":"PET positive, PET negative, or PET peeve?","volume":"115","author":"JW Friedberg","year":"2010","journal-title":"Blood"},{"key":"pone.0231027.ref021","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00259-010-1546-6","article-title":"Interim PET in lymphoma: a step towards standardization","volume":"37","author":"M Meignan","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref022","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","article-title":"qPET\u2014a quantitative approach to assess response in interim FDG-PET scans in lymphoma","volume":"41","author":"D Hasenclever","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref023","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00433459. accessed on 01.11.2019"},{"key":"pone.0231027.ref024","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02684708. accessed on 01.11.2019"},{"key":"pone.0231027.ref025","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","article-title":"High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group","volume":"17","author":"G Schellong","year":"1999","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref026","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","article-title":"Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study","volume":"28","author":"C Mauz-K\u00f6rholz","year":"2010","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref027","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7","article-title":"Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP","volume":"36","author":"G Bonadonna","year":"1975","journal-title":"Cancer"},{"key":"pone.0231027.ref028","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2009.23.3239","article-title":"Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244","volume":"27","author":"PJ Hoskin","year":"2009","journal-title":"J Clin Oncol"},{"key":"pone.0231027.ref029","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study","volume":"127","author":"SF Barrington","year":"2016","journal-title":"Blood"},{"key":"pone.0231027.ref030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim Positron Emission Tomography on Hodgkin lymphoma treatment outcome is confirmed using the 5-point scale interpretation criteria","volume":"99","author":"A Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"pone.0231027.ref031","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","article-title":"Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma","volume":"37","author":"SF Barrington","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref032","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers","volume":"54","author":"A Biggi","year":"2013","journal-title":"J Nucl Med"},{"key":"pone.0231027.ref033","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.semnuclmed.2017.01.001","article-title":"Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma","volume":"47","author":"R Kluge","year":"2017","journal-title":"Semin Nucl Med"},{"key":"pone.0231027.ref034","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00259-017-3853-7","article-title":"EANM\/EARL FDG-PET\/CT accreditation\u2014summary results from the first 200 accredited imaging systems","volume":"45","author":"A Kaalep","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref035","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00259-018-3977-4","article-title":"Feasibility of state of the art PET\/CT systems performance harmonisation","volume":"45","author":"A Kaalep","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref036","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"R Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0231027.ref037","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00259-013-2391-1","article-title":"Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients","volume":"40","author":"C Lasnon","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T13:37:58Z","timestamp":1585834678000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231027"}},"subtitle":[],"editor":[{"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231027","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}